Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Bernd Blank"'
Autor:
Monika Scheer, Christian Vokuhl, Bernd Blank, Erika Hallmen, Thekla von Kalle, Marc Münter, Rüdiger Wessalowski, Maite Hartwig, Monika Sparber‐Sauer, Paul‐Gerhardt Schlegel, Christof M. Kramm, Udo Kontny, Bernd Spriewald, Thomas Kegel, Sebastian Bauer, Bernarda Kazanowska, Felix Niggli, Ruth Ladenstein, Gustaf Ljungman, Kirsi Jahnukainen, Jörg Fuchs, Stefan S. Bielack, Thomas Klingebiel, Ewa Koscielniak, the Cooperative Weichteilsarkom Studiengruppe [CWS]
Publikováno v:
Cancer Medicine, Vol 8, Iss 2, Pp 527-542 (2019)
Abstract Background To evaluate optimal therapy and potential risk factors. Methods Data of DSRCT patients
Externí odkaz:
https://doaj.org/article/79f3876840a0491595c1f8b35a8e79a4
Autor:
Beat W. Schäfer, Ewa Koscielniak, Bernd Blank, Paolo Nanni, Peter Bode, Marco Wachtel, Maria E. Gierisch, Dominik Laubscher, Regina Hecker, David Herrero-Martin, Laura A. Lopez-Garcia, Verena Thalhammer
Supplementary Table S3. PAX3-FOXO1 phospho-peptides identified by mass spectrometry.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d49dfaa39017fb8bb19f4f8521f00cf
https://doi.org/10.1158/0008-5472.22406300
https://doi.org/10.1158/0008-5472.22406300
Autor:
Beat W. Schäfer, Ewa Koscielniak, Bernd Blank, Paolo Nanni, Peter Bode, Marco Wachtel, Maria E. Gierisch, Dominik Laubscher, Regina Hecker, David Herrero-Martin, Laura A. Lopez-Garcia, Verena Thalhammer
Pediatric tumors harbor very low numbers of somatic mutations and therefore offer few targets to improve therapeutic management with targeted drugs. In particular, outcomes remain dismal for patients with metastatic alveolar rhabdomyosarcoma (aRMS),
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8db77c9439699b7ea833a8851f179e2d
https://doi.org/10.1158/0008-5472.c.6507038
https://doi.org/10.1158/0008-5472.c.6507038
Autor:
Beat W. Schäfer, Ewa Koscielniak, Bernd Blank, Paolo Nanni, Peter Bode, Marco Wachtel, Maria E. Gierisch, Dominik Laubscher, Regina Hecker, David Herrero-Martin, Laura A. Lopez-Garcia, Verena Thalhammer
Supplementary Figure Legends. Legend for Supplementary Figures S1-S7.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd2f04dc5f923c21648c84f408f6dcac
https://doi.org/10.1158/0008-5472.22406315.v1
https://doi.org/10.1158/0008-5472.22406315.v1
Autor:
Beat W. Schäfer, Ewa Koscielniak, Bernd Blank, Paolo Nanni, Peter Bode, Marco Wachtel, Maria E. Gierisch, Dominik Laubscher, Regina Hecker, David Herrero-Martin, Laura A. Lopez-Garcia, Verena Thalhammer
Supplementary Materials and Methods. Description of additional methods and procedures used in the study.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::589222c131d0d9ec64e0f8537183cdbb
https://doi.org/10.1158/0008-5472.22406309.v1
https://doi.org/10.1158/0008-5472.22406309.v1
Autor:
Klingebiel, Ewa Koscielniak, Bernd Blank, Christian Vokuhl, Bernarda Kazanowska, Ruth Ladenstein, Felix Niggli, Gustaf Ljungman, Rupert Handgretinger, Guido Seitz, Jörg Fuchs, Birgit Fröhlich, Monika Scheer, Rüdiger Wessalowski, Irene Schmid, Monika Sparber-Sauer, Thomas
Publikováno v:
Cancers; Volume 14; Issue 4; Pages: 899
We report here the results of the prospective, non-randomized, historically controlled CWS-2002P study in patients ≤ 21 years with localized RMS developed with the aim to improve the long-term outcome by adapting the burden of therapy to risk profi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::6f1413ac528e5370d0f87c56fe2db971
Autor:
Ewa, Koscielniak, Bernd, Blank, Christian, Vokuhl, Bernarda, Kazanowska, Ruth, Ladenstein, Felix, Niggli, Gustaf, Ljungman, Rupert, Handgretinger, Guido, Seitz, Jörg, Fuchs, Birgit, Fröhlich, Monika, Scheer, Rüdiger, Wessalowski, Irene, Schmid, Monika, Sparber-Sauer, Thomas, Klingebiel
Publikováno v:
Cancers. 14(4)
We report here the results of the prospective, non-randomized, historically controlled CWS-2002P study in patients ≤ 21 years with localized RMS developed with the aim to improve the long-term outcome by adapting the burden of therapy to risk profi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d69f51fe1b9c1850e16ded3651dc7f81
https://pubmed.ncbi.nlm.nih.gov/35205646
https://pubmed.ncbi.nlm.nih.gov/35205646
Autor:
Ewa Koscielniak, Monika Sparber-Sauer, Bernd Blank, Gustaf Ljungman, Bernarda Kazanowska, Ruth Lydia Ladenstein, Felix Niggli, Joachim Boos, Rupert Handgretinger, Martin Zimmermann, Thekla von Kalle, Irene Teichert von Luettichau, Irene Schmid, Birgit Fröhlich, Hermann L. Müller, Christian Vokuhl, Wolfgang Behnisch, Erika Hallmen, Thomas Klingebiel
Publikováno v:
Journal of Clinical Oncology. 40:10033-10033
10033 Background: Low dose maintenance therapy as consolidation after multimodal standard therapy has been shown to improve survival in patients with sarcoma. It is however unclear which drugs and how long would be optimal. We investigated whether ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6806e0c3dd5330bc93f3c4c32d07a16c
https://doi.org/10.1200/jco.2022.40.16_suppl.10033
https://doi.org/10.1200/jco.2022.40.16_suppl.10033
Autor:
Jörg Fuchs, T. Kegel, Monika Scheer, Sebastian Bauer, Bernarda Kazanowska, Marc Münter, Stefan S. Bielack, Udo Kontny, Kirsi Jahnukainen, Thomas Klingebiel, Felix Niggli, Erika Hallmen, Paul-Gerhardt Schlegel, Gustaf Ljungman, Ewa Koscielniak, Christian Vokuhl, Christof M. Kramm, Maite Hartwig, Monika Sparber-Sauer, Bernd Blank, Rüdiger Wessalowski, Cooperative Weichteilsarkom Studiengruppe, Ruth Ladenstein, Thekla von Kalle, Bernd Spriewald
Publikováno v:
Cancer Medicine
Background: To evaluate optimal therapy and potential risk factors. Methods: Data of DSRCT patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4d5aac86730facdbb38022cedba3546
https://nbn-resolving.org/urn:nbn:de:bvb:20-opus-228444
https://nbn-resolving.org/urn:nbn:de:bvb:20-opus-228444
Autor:
Regina Hecker, Ewa Koscielniak, Peter K. Bode, Maria E. Gierisch, David Herrero-Martin, Bernd Blank, Laura A. Lopez-Garcia, Marco Wachtel, Verena Thalhammer, Dominik Laubscher, Paolo Nanni, Beat W. Schäfer
Publikováno v:
Cancer research
Pediatric tumors harbor very low numbers of somatic mutations and therefore offer few targets to improve therapeutic management with targeted drugs. In particular, outcomes remain dismal for patients with metastatic alveolar rhabdomyosarcoma (aRMS),
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfc4cf7f12fa4ffab3d378e31698de3b
https://doi.org/10.1158/0008-5472.can-14-1246
https://doi.org/10.1158/0008-5472.can-14-1246